Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Paolo Tarantino, Biagio Ricciuti, Shan Pradhan, Sara M. Tolaney
Topics & Concepts
MedicineTolerabilityAdverse effectDrugClinical trialIntensive care medicineOncologyPharmacologyInternal medicineHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy research